Investigating synthetic mimics of glycosaminoglycans to regulate blood cell production.
Official title: Synthetic glycosaminoglycan mimetics as regulators of megakaryopoiesis and thrombopoiesis
Funded at University of North Texas · NIH-11126986 · Data updated 2026-11-12
This study is looking at how special synthetic compounds can help boost the production of platelets, which are important for stopping bleeding, and it's aimed at finding new ways to improve blood clotting for people who might need it.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of North Texas NIH-funded |
| Lab location | 1 site (Denton, United States) |
| Project start | July 22, 2024 |
| Project end | June 30, 2027 |
| Funding year | 2024 |
| Award (this year) | $235,682 |
| NIH project number | 4R00HL161423-03 |
| Project ID | NIH-11126986 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals with conditions affecting platelet production or function, such as thrombocytopenia or thrombocytosis.
✕Less likely to help
Patients with stable platelet counts and no history of blood disorders may not benefit from this research.
What this research studies
This research focuses on understanding how synthetic glycosaminoglycan mimetics can influence the production of platelets from megakaryocytes, which are essential for blood clotting. The principal investigator, a postdoctoral scholar, will utilize advanced techniques to study the interactions between these mimetics and proteins involved in blood cell formation. By developing non-saccharide glycosaminoglycan mimetics, the research aims to uncover new regulatory mechanisms that could enhance or control platelet production in the body.
Why it matters
Potential benefit: If successful, this research could lead to new therapies for conditions related to abnormal platelet levels, improving patient outcomes in bleeding disorders or thrombosis.
How similar studies have gone: Previous research has shown promise in using glycosaminoglycan mimetics for various biological applications, suggesting potential for success in this novel approach.
Where this research is happening
-
University of North Texas
Denton, United States Active
Researchers
- Principal investigator: Afosah, Daniel Kwame — University of North Texas
- Study coordinator: Afosah, Daniel Kwame
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.